Presynaptic inhibition onto axons regulates neuronal output, but how such inhibitory synapses develop and are maintained in vivo remains unclear. Axon terminals of glutamatergic retinal rod bipolar cells (RBCs) receive GABA A and GABA C receptor-mediated synaptic inhibition. We found that perturbing GABAergic or glutamatergic neurotransmission does not prevent GABAergic synaptogenesis onto RBC axons. But, GABA release is necessary for maintaining axonal GABA receptors. This activitydependent process is receptor subtype specific: GABA C receptors are maintained, whereas GABA A receptors containing a1, but not a3, subunits decrease over time in mice with deficient GABA synthesis. GABA A receptor distribution on RBC axons is unaffected in GABA C receptor knockout mice. Thus, GABA A and GABA C receptor maintenance are regulated separately. Although immature RBCs elevate their glutamate release when GABA synthesis is impaired, homeostatic mechanisms ensure that the RBC output operates within its normal range after eye opening, perhaps to regain proper visual processing within the scotopic pathway.
INTRODUCTION
Presynaptic inhibition onto axonal terminals, commonly provided by GABAergic transmission, regulates neurotransmitter release. GABA receptors on the axon hillock of pyramidal cells (Nusser et al., 1996; Szabadics et al., 2006) , on mossy fiber terminals of hippocampal granule cells (Ruiz et al., 2003) , on cerebellar parallel fibers (Stell et al., 2007) , and on retinal bipolar cell axon terminals (Shields et al., 2000; Vardi and Sterling, 1994) serve to modulate action potential firing and neurotransmitter release (Kullmann et al., 2005; Luscher et al., 2011) . Although much is known about how presynaptic GABAergic inhibition shapes neuronal output, mechanisms that regulate the development and maintenance of such inhibition onto axon terminals are not yet well understood. Here, we addressed the role of neurotransmission in the development, maturation, and maintenance of GABAergic synapses onto axonal terminals involved in modulation of neurotransmitter release. To do so, we took advantage of a well-characterized circuit in the mammalian retina, where glutamate release from axons is regulated by robust presynaptic GABAergic inhibition.
At dim light levels, visual information from rod photoreceptors is conveyed to rod bipolar cells (RBCs) , which relay the signal to amacrine cells in the inner retina (reviewed by Wä ssle, 2004) . Specifically, RBCs contact GABAergic A17 amacrine cells (A17s) (Nelson and Kolb, 1985) , which provide local feedback inhibition onto the rod bipolar cell axon terminals to modulate their release of glutamate (Chá vez et al., 2006; Chun et al., 1993; Hartveit, 1999) . In addition, RBC axon terminals also receive GABAergic drive from other widefield amacrine cells (Chá vez et al., 2010; McGuire et al., 1984) . Unlike other parts of the brain in which GABAergic inhibition is mediated mainly by GABA A receptors, GABAergic input onto RBC axon terminals involves both GABA A and GABA C receptor types (Enz et al., 1996; Koulen et al., 1998) . GABA A and GABA C receptors do not cocluster at the same synaptic site but are expressed at different postsynaptic sites on RBC axon terminals Koulen et al., 1998) . There are also functional differences between the two receptor types: GABA A receptors are less sensitive to GABA but have faster kinetics compared to GABA C receptors, and thus the two receptor types regulate different aspects of glutamate release from RBCs (Eggers and Lukasiewicz, 2006b; Sagdullaev et al., 2006) . The diversity of GABA receptors on RBCs presents an ideal opportunity to investigate how neurotransmission regulates the development and maintenance of not only GABA receptors but also different GABA receptor types on the same axon terminal.
To examine the role of neurotransmission on the formation and maintenance of axonal GABA receptors, we utilized transgenic mice in which GABAergic or glutamatergic transmission is perturbed throughout the period of circuit assembly. Using electron microscopy, immunohistochemistry, and electrophysiology, we assessed whether perturbed neurotransmission affects the structural formation and maintenance of GABA receptor subtypes on RBC axon terminals. Because RBC terminals also receive some glycinergic inhibition (Eggers et al., 2007 , Wä ssle et al., 2009 ), we further analyzed whether an upregulation of glycine receptors occurred to compensate for the reduction in GABAergic transmission. Furthermore, we asked whether the loss of GABAergic inhibition causes alterations to RBC output beyond that expected solely from disinhibition in the GABA-deficient circuit. Because GABA release from A17 amacrine cells normally requires RBC drive due to the reciprocal synaptic arrangement between these two cell types, we determined In turn, they receive feedback inhibition from A17 cells and additional GABAergic input from other as-yet-unidentified amacrine cells (AC; red). (B) PKC-labeled RBC terminals (red) colabeled with GAD67 or GAD65 (cyan) reveal more abundant immunoreactivity of GAD67 as compared to GAD65 in the IPL lamina, where RBC axons stratify. (C) Quantification of percent volume of GAD signal overlapping with PKC immunoreactivity revealed a significantly higher percent overlap with GAD67-positive processes as compared to GAD65. Asterisk marks significant difference. (D) Development of contacts (arrows) between RBCs (red) and GAD67-GFP-positive amacrine processes (cyan) in the grm6-tdtomato 3 GAD67-GFP double transgenic line. By P15, large varicosities can be seen at sites of contact between RBC axon terminals and GAD67-GFP amacrine processes. (E) Axonal terminals of P12 PKC-labeled RBCs (blue) express GABA A a1, GABA A a3, and GABA C r receptor clusters (yellow), indicating the presence of these three GABAergic postsynapses on RBC terminals before eye opening. (F) P30 RBCs in the grm6-tdtomato transgenic line (left, vertical view, grayscale) . Axonal terminals of individual P30 RBCs (horizontal view, blue) express all three GABA receptor cluster types: GABA A a1, GABA A a3, and GABA C r (yellow). See also Figures S1 and S2.
whether lack of GABAergic transmission also caused developmental changes in the glutamatergic synapses of A17 amacrine cells.
RESULTS

Development of GABAergic Synapses on RBC Axon Terminals
GABAergic inhibition onto axon terminals of RBCs is mediated by a variety of amacrine cells, including A17 cells that provide reciprocal feedback inhibition ( Figure 1A ). GABA is synthesized in amacrine cells by two isoforms of glutamate decarboxylase, GAD67 and GAD65 (Haverkamp and Wä ssle, 2000; Vardi and Auerbach, 1995) . We found that in the sublamina of the inner plexiform layer (IPL) where RBC axonal terminals stratify (sublamina 5, ON-layer), GAD67 immunoreactivity was more abundant compared to GAD65 ( Figure 1B) . Quantification of the immunolabeling (see Experimental Procedures) showed that dendritic processes positive for GAD67 exhibited greater volume overlap with protein kinase C (PKC) immunoreactive RBC axonal boutons, compared to GAD65 containing processes ( Figure 1C ), suggesting that GAD67-positive amacrine cell processes provide the majority of GABAergic inhibition onto RBC axon terminals.
To visualize amacrine cell contacts onto RBC terminals during development, we utilized the GAD67-GFP transgenic line (Chattopadhyaya et al., 2004) , where a fraction of GAD67-positive amacrine cells (Figure S1A available online) express GFP. Amacrine cells typically synapse onto bipolar cell axons at enlarged varicosities (Dowling and Boycott, 1966) . Using the GAD67-GFP transgenic line, we visualized large varicosities of GFPlabeled amacrine processes contacting RBC boutons at sites immunopositive for GAD67, but not GAD65 ( Figure S1B ). We further determined when GABAergic contacts develop on RBCs, labeled by expression of the fluorescent protein tdtomato under the grm6 promoter ( Figure 1D ). Appositions between GAD67-GFP positive processes and RBC axonal boutons were already apparent at postnatal day (P) 10 ( Figure 1D ), several days after axonal differentiation in the bipolar cells (Morgan et al., 2006) . At P15, large varicosities were clearly present at sites of contact between amacrine cell dendrites and RBC boutons, which remained evident at P21. We previously found that spontaneous GABAergic inhibitory postsynaptic currents (sIPSCs) can be recorded from RBCs from P10 (Schubert et al., 2008) . Thus, the appearance of structural contacts between GABAergic amacrine cells and RBC axon terminals coincides with the emergence of sIPSCs in RBCs. This suggests that functional postsynaptic GABA receptor clusters are already present on RBC terminals before eye opening (P15).
Previous studies demonstrated that GABA A and GABA C receptors are present on axon terminals of RBCs across species Koulen et al., 1997 Koulen et al., , 1998 Lukasiewicz, 1996 Lukasiewicz, , 2004 Enz et al., 1996; McCall et al., 2002) . To monitor the appearance of GABA receptor clusters on RBC axonal boutons during circuit assembly, we labeled for GABA A and GABA C receptors at two developmental time points, before eye opening (P12) and at maturity (P30). We found abundant GABA C receptor clusters on PKC-labeled axon terminals of RBCs as early as P12 and at P30 (Figures 1E and 1F) . To determine the subunit composition of the GABA A receptor clusters located at these terminals, we performed immunostaining for GABA A a1-a3 subunits together with PKC. a2-containing GABA A receptors were not present on RBC axon terminals ( Figure S2A ), supporting past findings . In contrast, both a1-and a3-containing GABA A receptor clusters were localized on RBC axonal boutons at both ages examined ( Figures 1E and 1F ). GABA A synapses containing a1 or a3 subunits did not colocalize with GABA C receptors ( Figure S2B ) as found previously in adult retina (Koulen et al., 1996; Wä ssle et al., 1998) . Furthermore, these three GABA receptor cluster types (a1-GABA A , a3-GABA A , and GABA C ) on RBC boutons were each apposed to large GAD67-GFP amacrine cell varicosities ( Figure S1C ). Coimmunolabeling for GAD67 and GABA receptors revealed that 93.27% ± 0.48% of GABA A a1 (n = 2 animals), 93.89% ± 0.66% of GABA C (n = 2), and 79.30% ± 2.04% of GABA A a3 (n = 3) receptor clusters on RBC terminals were apposed to GAD67-positive terminals. Thus, all three GABA receptor types are present on RBC terminals before eye opening, suggesting that synapses comprising these receptor types develop concurrently.
Synaptic Contacts between RBCs and Amacrine Cells Form Despite Reduction of GABAergic or Glutamatergic Neurotransmission
To determine the role of neurotransmission in the structural development of inhibitory synapses onto RBC axon terminals, we used two transgenic mouse lines (Figure 2A ). First, we asked whether suppressing glutamatergic transmission onto amacrine cells that likely contact RBCs affects the development of amacrine cell synapses onto RBC axons. This was achieved using the grm6-TeNT line in which neurotransmission from all ONbipolar cells, including RBCs, is suppressed by expression of the light chain of tetanus toxin (Kerschensteiner et al., 2009 ). Next, we assessed the outcome when GABA release from amacrine cells is diminished from development onward. To do so, we crossed GAD1 conditional knockout (KO) mice (Chattopadhyaya et al., 2004) with aPax6-Cre mice in which cre-recombinase expression is limited to the retina, to generate GAD1KO mice Figure S3 . (Schubert et al., 2010) (Figure S3 ). In GAD1KO retina, the level of GAD67 expression is reduced ( Figure S3A ), and immunolabeling for GAD67 reveals that loss of GAD67 (in the knockout region) occurs outside a dorsal-ventral strip (the WT region) in which cre-recombinase is largely absent (Figures S3B and S3C ; see Marquardt et al., 2001) . We use ''GAD1KO'' from here on to refer to the knockout regions.
We compared vesicular inhibitory amino acid transporter (VIAAT) immunolabeling across wild-type, grm6-TeNT, and GAD1KO retinas to assess whether amacrine cell terminals surrounding RBC axons failed to differentiate when neurotransmission is perturbed. We found no gross changes in the density of VIAAT labeling surrounding P30 RBC axonal terminals in either transgenic line, suggesting that amacrine cell-RBC synapses still formed ( Figure 2B ). We confirmed that amacrine cell-RBC synapses still formed in the mutant mice, by examining the ultrastructural arrangement of RBC axonal boutons in both grm6-TeNT and GAD1KO retina. In both lines, amacrine cells still synapsed onto RBC boutons, and these synapses were apparent at eye opening (P15) (n = 14 GAD1KO; n = 26 TeNT RBC boutons examined) as in wild-type animals ( Figure 2C ). However, some aspects of the synaptic arrangements differed between grm6-TeNT and GAD1KO retinas. P30 RBC boutons formed dyad synapses at sites containing a single ribbon in the GAD1KO (n = 20 RBC synapses per genotype), but such arrangements were disrupted in grm6-TeNT retinas, where sometimes multiple ribbons were apposed to a single postsynaptic density (n = 16 of 26 at P15, and 13 of 23 synaptic sites had >1 ribbon at P30; e.g., Figure 2C ), as shown previously (Kerschensteiner et al., 2009) . Thus, although the ribbon arrangement of the RBC is differentially affected in grm6-TeNT and GAD1KO retinas, the amacrine cell-RBC synapse forms and is maintained regardless of whether bipolar or amacrine cell transmission is perturbed.
Development and Maintenance of GABAergic Synapses on RBC Axon Terminals Do Not Rely on Glutamatergic Transmission
Although amacrine cell synapses are present structurally on RBC terminals in grm6-TeNT retinas, it is possible that suppression of glutamatergic drive from bipolar cells leads to alterations in GABA-mediated transmission onto RBC axon terminals. We thus performed whole-cell recordings on wild-type and grm6-TeNT RBCs and analyzed spontaneous GABAergic inhibitory postsynaptic currents (sIPSCs) ( Figure 3A ). Spontaneous IPSCs in both genotypes were comparable in mean frequency and amplitude at both P11-P13 and P30, indicating that the number of GABAergic synaptic contacts and the size of postsynaptic GABA receptor clusters were not significantly affected by a reduction of glutamatergic input to amacrine cells ( Figure 3B ). To evoke release of GABA from presynaptic amacrine cells, we puffed a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) at the axon terminal of RBCs (Chá vez et al., 2006) and recorded the evoked PSCs at 0 mV holding potential ( Figure 3C ). The mean charge of AMPA-evoked currents was not different in wild-type and grm6-TeNT RBCs at both P11-P13 and P30 ( Figure S4 ). To distinguish GABA A and GABA C components of the evoked response, AMPA puffs were repeated in the presence of (1,2,5,6-tetrahydropyridine-4yl) methyphospinic acid (TPMPA) (GABA C receptor antagonist) or SR95531 (GABA A receptor antagonist) ( Figure 3C ). Quantification of mean charge and amplitude (data not shown) of the evoked response (total, GABA A , or GABA C ) showed no significant differences between RBCs in wild-type and grm6-TeNT retinas at P11-P13 ( Figure 3D ) and at P30 ( Figure 3E ). Together, these results suggest that functional GABAergic synapses are formed normally and maintained even when the bipolar cells fail to transmit effectively to amacrine cells.
RBC Responses to GABA Application Decline with Maturation in the GAD1 Mutant
To assess the functional consequences of reduced GABA synthesis on the formation and maintenance of inhibitory synapses onto RBC axon terminals, we performed whole-cell recordings of these neurons in the GAD1KO retina. As expected, spontaneous inhibitory postsynaptic currents (sIPSCs) were rare in GAD1KO at both ages examined (Figures 4A and 4B) . This indicates that deletion of GAD67 was not accompanied by a compensatory upregulation of the other GABA synthesizing enzyme, GAD65. Because synaptic release of GABA in these mutants is greatly impaired, we puffed GABA onto GAD1KO RBC axon terminals and recorded the evoked chloride currents in order to assess whether any postsynaptic changes occurred in GAD1KO RBCs. Interestingly, RBC responses to GABA application in GAD1KO were unchanged at P11-P13 but were dramatically reduced at P30 (example recordings in Figure 4C ). Both mean amplitude and charge of the evoked responses decreased by P30 ( Figure 4D ). Moreover, the rise time was slower for evoked responses in P30 GAD1KO RBCs, whereas their decay time was faster, as compared to control ( Figure 4E ). Thus, GABAergic transmission plays an important role in the maintenance, although not in the initial formation, of functional GABAergic synapses on RBC axon terminals.
In wild-type animals, RBCs receive little glycinergic input (Eggers et al., 2007) . Indeed, immunolabeling for the a1 or a2 subunit of the glycine receptor (Ivanova and Mü ller, 2006; Wä ssle et al., 2009) showed little glycine receptor expression on RBC axon terminals ( Figures S5A and S5B ). However, a severe reduction of GABAergic transmission in GAD1KO may be compensated for by an upregulation of glycine receptor-driven input onto RBC axon terminals. We investigated this possibility by quantifying the expression of glycine receptors containing a1 or a2 subunits on RBC axon terminals in GAD1KO retina. But, we did not find any upregulation of these glycine receptor subtypes in the RBC terminals of GAD1KO ( Figure S6 ).
GABA A and GABA C Receptors on RBC Axon Terminals Are Differentially Altered in GAD1KO Because GABA A and GABA C receptor clusters are found at distinct postsynaptic sites on RBC axon terminals, we next asked whether loss of GABAergic transmission affected both receptor types. Figure 5A shows examples of the GABA-evoked responses of P30 RBCs from a littermate control and a GAD1KO animal in which the GABA A component is revealed upon blocking the GABA C receptor-mediated current. Quantification of the mean amplitude and charge of the evoked GABA A responses in RBCs revealed significant reduction in the knockout animal ( Figure 5B) . Similarly, the evoked GABA C responses were isolated for RBCs in GAD1KO and control upon blocking GABA A currents ( Figure 5C ). In contrast to GABA A -mediated responses, the mean amplitude of the GABA C -mediated response was unchanged ( Figure 5D ). However, the net charge carried by the GABA C currents was significantly reduced in GAD1 ( Figure 5D ). This may reflect faster GABA C -mediated response kinetics in RBCs from GAD1KO compared to littermate control (see Figure 4E ).
To correlate these functional changes at P30 with the expression of GABA A and GABA C receptor types, we immunostained for the a1 and a3 subunits of the GABA A receptors and the r sub- units of the GABA C receptors. We compared the immunolabeling of P30 knockout regions in the GAD1 mutant with corresponding wild-type regions (which provides an ideal control because these regions are within the same retina) as well as with littermate control retinas. For GABA A receptors, GAD67 immunostaining was used to distinguish knockout regions from wild-type regions in GAD1KO ( Figures 6A and 6B ). However, we could not colabel GAD67 and GABA C receptors due to species specificity of the antibodies. Instead, we used the GFP signal to identify the knockout regions because GFP is expressed specifically in cells in which the GAD1 exon is excised (Marquardt et al., 2001) . Overall, immunoreactivity for a1-containing GABA A receptors was significantly reduced in the knockout region compared to the wild-type region and littermate control ( Figure 6A ). In contrast, a3-containing GABA A receptor labeling did not appear to have changed in the knockout regions (Figure 6B) . Similarly, GABA C receptor staining was comparable across regions and genotypes ( Figure 6C ). Because of the high density of GABA receptor clusters on RBC boutons, it was not always possible to separate individual clusters. Thus, instead of determining the number of receptor puncta, we quantified the percent volume occupied by each receptor subtype on PKC-positive RBC boutons (see Experimental Procedures). We found that the percent volume occupied by a1-containing GABA A receptors, but not a3-containing GABA A receptors or GABA C receptors, was significantly reduced in the knockout regions ( Figure 6 ). This reduction of GABA A a1 clusters in GAD67-deficient regions was corroborated by using another GABA A a1 antibody raised in a different species ( Figure S6A ). To assess whether GABA A a1 synthesis levels in GAD1KO retina was diminished overall, we performed western blot analysis using P30 retina homogenates from which the dorsal-ventral wedge was removed. The total GABA A a1 synthesis levels in the GAD1KO mutant was comparable to littermate control samples (Figure S6B ; n = 2 GAD1KO and 2 littermate controls), suggesting that overall synthesis of GABA A a1 receptors in GAD67-deficient retina was unchanged. The reduction in immunostaining for GABA A a1 in the GAD1KO is thus unlikely to be caused by an alteration in receptor synthesis and is more likely the result of a deficit in the maintenance of GABA A a1 clusters on RBC terminals. Because we found little expression of the known inhibitory postsynaptic scaffolding proteins, Neuroligin2 and Gephyrin, at GABA A receptors in RBC axon terminals ( Figures S5B and  S5C ), we decided against analyzing the expression levels of these proteins in GAD1KO RBCs. Taken together, our findings demonstrate that GABA A and GABA C receptors on RBC axon terminals are differentially maintained by GABAergic transmission.
The specific reduction of GABA A and not GABA C receptor clusters in GAD1KO RBCs suggests an independent regulation of the maintenance of these two ionotropic GABA receptor types that coexist on the same axonal terminal. To further test this hypothesis, we immunolabeled a1-containing GABA A receptor clusters in GABA C KO mice (McCall et al., 2002) (Figure S7 ). We found no alteration in the percent volume occupied by a1-containing GABA A receptors in P30 GABA C KO RBC terminals ( Figure S7 ). Thus, we conclude that there exists independent regulatory mechanisms for maintaining GABA A and GABA C receptor clusters on RBC axon terminals.
Reduced GABAergic Drive Transiently Increases Glutamate Release from Developing RBCs
GABAergic A17 amacrine cells form reciprocal synapses with glutamatergic RBCs. We thus wondered whether there were corresponding changes in the RBC input onto the A17 cells in GAD1KO. We compared RBC input onto A17 cells in GAD1KO with wild-type littermate controls at two developmental time points, P11-P13 and P30, by recording spontaneous excitatory postsynaptic currents (sEPSCs) from A17 amacrine cells. In littermate controls, the mean frequency of sEPSCs in these amacrine cells normally increased with age ( Figures 7A and 7B) . In GAD1KO, the mean frequency of sEPSCs from A17 amacrine cells at P11-P13 was significantly higher compared to their control littermates (Figures 7A and 7B ). In the KO, there was no further increase in sEPSCs frequency in the A17 cells with maturation ( Figures 7A and 7B) , and in fact, the P11-P13 sEPSCs were already comparable to that of P30 controls. These observations together suggest that although the RBC output is initially elevated during development when inhibition is reduced, homeostatic mechanisms ensure that the bipolar cell output operates within its normal range at maturity ( Figure 7B ).
Is the transient increase in frequency of the sEPSCs from developing A17 cells in the KO simply a result of reduced inhibition onto the RBC axonal terminals? To answer this, we recorded sEPSCs from A17s in P11-P13 GAD1KO and littermate control animals in the presence of GABA A and GABA C receptor blockers, SR95531 and TPMPA, respectively ( Figure 7C) . Even in the presence of GABA receptor blockers, P11-P13 A17 cells showed an increased frequency of sEPSCs in GAD1KO as compared to control ( Figure 7C ), suggesting that there is an upregulation of glutamatergic drive onto A17 cells in GAD1KO. This upregulation, however, is not the consequence of perturbed GABA C -receptor mediated transmission, despite GABA C receptors carrying the majority of the total charge transfer (Figures 5B and 5D; Eggers and Lukasiewicz, 2006a; McCall et al., 2002) . In the presence of a GABA A receptor antagonist, the mean sEPSC frequency of P11-P13 A17 cells in the GABA C receptor KO is not significantly different from that of littermate controls ( Figure S8 ).
Could the upregulation of glutamatergic drive onto developing A17 cells be due to changes in receptor density on A17 cells? We found that at P11-P13, the mean amplitude of the sEPSCs was unchanged for A17s in GAD1KO ( Figures 7D and 7E) , indicating that the glutamate receptor density at individual postsynaptic sites is not altered. Also, A17 cell responses to AMPA puffs revealed no differences between GAD1KO and control ( Figures  7F and 7G) . Thus, the total density (or number) of glutamatergic synapses on A17s is unperturbed in GAD1KO animals ( Figures  7D-7G ). This suggests that the increase in A17 sEPSC mean frequency in GAD1KO is not the result of changes in glutamate receptor density on the A17 cell but is more likely due to presynaptic changes, such as the probability of release, in the RBC terminal.
DISCUSSION
We found that RBC axon terminals receive GABAergic inhibition from GAD67-positive amacrine cells via three distinct GABA receptor subtypes (GABA A a1, GABA A a3, and GABA C ). Using mutant mice, we found that GABAergic synapses are still established on RBC axonal terminals when either glutamatergic or GABAergic transmission is perturbed. However, the maintenance of GABA A a1 receptor clusters on RBC axonal terminals is selectively disturbed when GABA synthesis is much reduced in the presynaptic amacrine cells (Figure 8) . Further, the maintenance of GABA A a1 receptor clusters is not dependent on the presence or synaptic drive via GABA C receptors. We also discovered that glutamate release from developing RBCs increased in the GAD1KO, but not in the GABA C KO retinas (Figure 8 ).
GABAergic Synapse Maintenance, but Not Formation, on Axon Terminals Is Influenced by GABAergic Transmission
How neurotransmission modulates the formation of inhibitory synapses has primarily been addressed for synapses onto somata and dendrites of neurons (Chattopadhyaya et al., 2007; Hartman et al., 2006; Harms and Craig, 2005; Kilman et al., 2002) . Recently, GABAergic transmission was found to regulate the maturation of basket interneuron axonal terminals . Here, we assessed the importance of neurotransmission in the development of GABAergic synapses on glutamatergic axon terminals, focusing on amacrine cell-RBC connectivity. Our results demonstrate that presynaptic GABAergic amacrine cells do not require glutamatergic drive from bipolar cells to establish their inhibitory synapses onto bipolar cell axons. Prior work has demonstrated that GABAergic transmission is not essential for inhibitory synapse formation on dendrites and somas per se (Chattopadhyaya et al., 2007; Wojcik et al., 2006; Wu et al., 2012) . We found this to also be true for inhibitory synapse formation onto axon terminals as amacrine cell-RBC synapses are evident in the retinal-specific GAD1KO. Reduction of GAD67 in basket cells of the visual cortex, however, results in fewer perisomatic inhibitory synapses on pyramidal neurons (Chattopadhyaya et al., 2007) . This reduction in inhibitory synapse number onto the cell bodies appears to be due to the lack of GABAergic transmission during synaptogenesis, rather than a failure to maintain established synapses. In the retina, we found that reducing GABAergic transmission during development affects the maintenance of GABA receptors on the RBC axons, but not the initial formation of these synapses. From previous work (Burrone and Murthy, 2003; Pozo and Goda, 2010; Turrigiano, 2007) , we had expected that RBCs in GAD1KO might undergo homeostatic adjustment and recruit more GABA receptors to their axons to compensate for reduced GABAergic transmission.
Instead, we observed that RBC axon terminals lose GABA receptors at maturity when presynaptic GABA release is reduced chronically.
Activity-Dependent Maintenance of Axonal GABA Receptors Is Receptor Subtype Specific
To date, most studies focusing on the activity-dependent maintenance of GABA A receptors in neurons have assessed the distribution of the entire GABA A receptor population, irrespective of their subunit composition. This is because in most parts of the nervous system, GABA A receptors can comprise mixed a subunits together with b and g subunits (Fritschy and Mohler, 1995; Kasugai et al., 2010) . However, in the mammalian retina, three distinct subtypes of GABA A receptors can be distinguished by the presence of specific a subunits (a1-a3) localized at nonoverlapping synapses (Koulen et al., 1996; Wä ssle et al., 1998) . On mouse RBC axon terminals, we identified two types of GABA A receptor synapses, containing either the a1 or a3 subunit. Both these GABA A receptor types were apposed to GAD67-positive processes but, functionally, they could provide GABA A receptor-mediated inhibition with different time courses, because a1-containing GABA A receptors exhibit faster response kinetics compared to a3-containing receptors (Gingrich et al., 1995; Ortinski et al., 2004; Vicini et al., 2001) . Surprisingly, we found that reduced GABAergic neurotransmission selectively regulated the maintenance of GABA A a1, but not GABA A a3, receptor clusters.
Reducing GABAergic transmission also differentially affected the maintenance of the two ionotropic GABA receptor types (GABA A and GABA C ) on RBC axons. Whereas the amplitude of the GABA A receptor component of the GABA-evoked response was decreased at P30 in GAD1KO, there was no change in amplitude of the GABA C component. Our immunostaining for GABA A and GABA C receptors supported this differential reduction in GABA A versus GABA C receptors on RBC axons. What might be the differences in GABA A and GABA C receptors that could account for this differential outcome in the GAD1KO? GABA C receptors have a higher affinity for GABA compared to GABA A receptors (Feigenspan and Bormann, 1994) . Perhaps these receptors require only low levels of GABA for their maintenance. GABA A and GABA C receptors do not colocalize at the same postsynaptic sites Koulen et al., 1998) . Thus, it could also be that these two GABA receptor types are differentially positioned on the RBC terminal relative to the GABA release site, such that GABA A receptors normally ''sense'' higher GABA levels compared to GABA C receptors and thus need a substantial amount of GABA in the synaptic cleft for their maintenance. We further showed that loss of GABA C receptors per se does not affect the maintenance of GABA A a1 receptors in RBC terminals. We found no downregulation of GABA A receptors in GABA C KO retina. Furthermore, in GABA C KO retina, the function of glycine receptors (Eggers and Lukasiewicz, 2006a) on RBCs axon terminals is not affected. Accordingly, in GAD1KO we found no upregulation of glycine receptor clusters on RBC axon terminals. Taken together, our observations highlight independent mechanisms for regulating the distribution and density of distinct inhibitory receptor types (GABA receptors versus glycine receptors, GABA A versus GABA C receptors, and GABA A a1 versus GABA A a3 receptor types) on the same RBC axon terminal.
What underlies the eventual reduction of a1-containing GABA A receptors in GAD1KO? The role of activity in inhibitory receptor accumulation has been addressed in spinal cord cultures, where blocking neuronal activity by tetrodotoxin (TTX) application prevented glycine receptor accumulation (Kirsch and Betz, 1998) . However, our physiological recordings suggest that GABA receptors accrue normally on RBC axons initially (P11-P13), and total GABA A a1 synthesis in adult (P30) GAD1KO retina also appeared unimpaired. Another possibility is a failure to stabilize GABA A a1 receptor clusters after they have formed at synapses (Saliba et al., 2007) . Tracking movements of the inhibitory postsynaptic scaffold protein gephyrin in dissociated spinal cord neurons previously demonstrated activitydependent stabilizations of the gephyrin-fluorescent protein conjugates at synaptic versus extrasynaptic locations (Hanus et al., 2006) . The phenotypic alterations we observed in density of a1-containing GABA A receptors on RBC axons in GAD1KO could be a result of failed stabilizations of GABA A receptors at this synapse. This could lead to greater receptor internalization and subsequent degradation detectable as reduced receptor volume occupancy. Indeed, blocking neuronal activity has been shown previously to induce ubiquitination and degradation of GABA A receptors (Luscher et al., 2011) . However, because Neuroligin2 and Gephyrin do not appear to be at all GABA A a1 receptor clusters on the RBCs, future work is necessary to identify the postsynaptic scaffold proteins at the RBC axonal GABA receptors before we can systematically investigate the molecular mechanisms underlying the loss of GABA A a1 receptor clusters on RBC axon terminals in the GAD1 mutant.
RBCs Adjust Their Output Homeostatically in Response to Reduced GABAergic Drive
We found that RBCs increase their output onto A17 amacrine cells with maturation. Our study shows that this output is structurally and functionally modified by alterations in neurotransmission during development and circuit maturation. When glutamate release from RBCs is suppressed by TeNT expression in these cells, more ribbons are often recruited to RBC output sites. When GABAergic transmission is impaired, glutamate release from developing RBC terminals is increased beyond that expected solely from disinhibition in the GABA-deficient circuit, perhaps as an attempt to facilitate GABA release from the ''silenced'' A17 amacrine cells with which it shares a reciprocal synapse. Interestingly, this increase in glutamate release in developing RBCs in GAD1KO retinas does not appear to evoke a change in glutamate receptor density on the A17 amacrine cell. The lack of a complementary change in the A17 cell is unexpected for two reasons: (1) the RBC-A17 synapse is bidirectional, and (2) in other systems, downregulation of postsynaptic glutamate receptors occurs when there is enhanced presynaptic glutamate release due to homeostatic mechanisms coming into play (Burrone and Murthy, 2003; Pozo and Goda, 2010; Turrigiano, 2007) . In GAD1KO, RBC output further undergoes homeostatic regulation with maturation to ''cap'' or limit its output with circuit maturation, perhaps to maintain normal processing in the scotopic pathway involving the other postsynaptic partner, the AII amacrine cell (Bloomfield and Dacheux, 2001) . This later homeostatic regulation of RBC output parallels the loss of GABA A receptors on RBCs, but these events are unlikely to be related. This is because the progressive loss of Schematic illustrating the A17-RBC synapse before and after eye opening in wild-type, GAD1KO, and GABA C KO retina. GABA and glutamate release are similar between wild-type and GABA C KO (see also Eggers and Lukasiewicz, 2006a) but is altered in GAD1KO. There is a transient upregulation of glutamate release from developing RBCs in GAD1KO before eye opening. However, after eye opening, glutamate release from RBCs in GAD1KO becomes comparable to wild-type. GABA A , and not GABA C , receptors are selectively reduced at maturity in GAD1KO. This reduction of GABA A receptors on RBCs does not occur in GABA C receptor mutants.
GABA receptors does not affect inhibition on RBCs as there is little GABA release in GAD1KO. Our results highlight divergent mechanisms behind the regulation of output from RBC axon terminals and GABA receptor maintenance on these terminals. Our current findings also underscore the importance of assessing changes in GABA receptors on axons in addition to the somata and dendrites of neurons for understanding neurodevelopmental disorders, such as schizophrenia, where GABAergic transmission is perturbed (Lewis et al., 2005; Wassef et al., 2003) .
EXPERIMENTAL PROCEDURES Transgenic Mouse Lines
Several transgenic mouse lines were used in this study. In the GAD67-GFP (G42) line, the GAD67 promoter drives GFP expression in a fraction of GABAergic amacrine cells (Chattopadhyaya et al., 2004) . In the grm6-tdtomato mouse line, the red fluorescent protein tdtomato is expressed specifically by ON-bipolar cells under the mGluR6 promoter (Kerschensteiner et al., 2009) . In GAD1/lox/lox mice (Chattopadhyaya et al., 2007) , exon 2 of GAD1, the gene encoding GAD67 (Bu et al., 1992) , is flanked by loxP sites. To obtain retina-specific excision of exon 2, this line was bred to the a-Cre line, in which Cre-recombinase expression is regulated by the alpha enhancer of the Pax6 promoter (Marquardt et al., 2001 ). The excision of exon 2 in cells expressing Cre-recombinase results in a frameshift mutation of GAD1 (Chattopadhyaya et al., 2007) . We refer to this double transgenic line as GAD1KO. To abolish glutamatergic transmission in RBCs, we used grm6-TeNT transgenic in which the light chain of tetanus toxin is expressed specifically in ON-bipolar cells (Kerschensteiner et al., 2009) . To eliminate GABA C receptors from the retina, the gene encoding GABACr1 subunit was inactivated (McCall et al., 2002) ; we refer to these mice as GABA C KO.
Immunohistochemistry
Animal protocols were approved by the Institutional Animal Care and Use Committee at the University of Washington. All procedures were in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Mice deeply anaesthetized with Isoflurane were decapitated and enucleated. The cornea was punctured with a 30 gauge needle, and the retinas were removed in cold oxygenated mouse artificial cerebrospinal fluid (mACSF [pH 7.4]) containing (in mM) 119 NaCl, 2.5 KCl, 2.5 CaCl 2 , 1.3 MgCl 2 , 1 NaH 2 PO 4 , 11 glucose, and 20 HEPES. For vibratome sectioning, the retina was fixed for 20 min in 4% paraformaldehyde in mACSF (pH 7.4). For fixed flat-mount preparations, retinas were isolated and mounted retinal ganglion cell side up on black membrane filters (HABP013, Millipore, Billerica, MA, USA). The retina and filter paper were then immersed in 4% paraformaldehyde in mACSF (pH 7.4) for either 15 min (for GABA A a1 and GABA A a3 immunolabeling) or 30 min (for GABA C labeling). After fixation, the tissue was washed in 0.1 M PBS (pH 7.4), preincubated in PBS containing 5% normal donkey serum (NDS) and 0.5% Triton X-100, and incubated with primary antibodies in the same solution. For retinal whole-mounts, primary antibody incubation was performed over three nights. Secondary antibody incubation was carried out in PBS, and retinas were subsequently mounted in Vectashield (Vector Labs, Burlingame, CA, USA). Immunolabeling was performed using antibodies against PKC (rabbit polyclonal, 1:1,000, Chemicon, Temecula, CA, USA, or mouse monoclonal, 1:1,000, Sigma-Aldrich, St. Louis), GAD67 (mouse monoclonal, 1:1,000, Chemicon), GAD65 (rabbit polyclonal, 1:1,000, Chemicon), VIAAT (guinea pig polyclonal, 1:1,000, Synaptic Systems, Goettingen, Germany), GFP (chicken polyclonal, 1:1,000, Abcam, Cambridge, UK), Glycine receptor a1 subunit (mouse monoclonal mAb2b, 1:500, Synaptic Systems), Glycine receptor a2 subunit (goat polyclonal, 1:300, Santa Cruz Biotechnology, Santa Cruz, CA, USA), Gephyrin (mouse monoclonal 3B11, 1:1,000, Synaptic Systems), Neuroligin2 (rabbit polyclonal, 1:4,000, kindly provided by F. Varoqueaux and N. Brose), GABA C r receptor subunit (rabbit polyclonal, 1:500, kindly provided by R. Enz), GABA A a1 receptor subunit (polyclonal guinea-pig, 1:5,000, kindly provided by J.M. Fritschy), GABA A a1 receptor subunit (polyclonal rabbit, 1:2,000, kindly provided by J.M. Fritschy), GABA A a2 receptor subunit (polyclonal guinea-pig, 1:2,000, kindly provided by J.M. Fritschy), and GABA A a3 receptor subunit (polyclonal guinea-pig, 1:3,000, kindly provided by J.M. Fritschy). Secondary antibodies utilized were either anti-isotypic Alexa Fluor conjugates (1:1,000, Invitrogen, Carlsbad, CA, USA) or DyLight conjugates (1:1,000, Jackson ImmunoResearch, West Grove, PA, USA).
Imaging and Analysis
Image stacks were acquired on an Olympus FV1000 laser scanning confocal microscope. Fixed tissue was imaged using a 1.35 NA 603 oil immersion objective at a voxel size of 0.069, 0.069, 0.3 mm or 0.051, 0.051, 0.3 mm (x, y, z) for images used in quantification. To visualize RBC-amacrine cell contacts at different developmental time points, we crossed the GAD67-GFP and grm6-tdtomato mouse lines and imaged the retinas using a custom-built two-photon microscope and an Olympus 603 water objective. Each optical plane was averaged three to four times. Raw image stacks were processed using MetaMorph (Molecular Devices, Sunnyvale, CA, USA) and Amira (Visualization Sciences Group, Burlington, MA, USA). For volume estimation, the PKC signal of RBC boutons was masked in three dimensions using the ''label field'' function of Amira. Subsequently, this PKC mask was multiplied with the GAD or GABA receptor channel to isolate signal specifically within the RBC boutons. Next, a constant threshold for image stacks from the same retina (including WT-KO region comparison across the retina), was applied to detect the volume occupied by the signal using the ''label voxel'' function of Amira. The percent of signal volume as compared to PKC mask volume was estimated using the ''tissue statistics'' function of Amira.
The specificity of GABA receptor antibodies utilized in this study was tested by performing colocalization analysis and assessing the extent of random associations (Soto et al., 2011) . In vertical retinal sections, we found 87% of GABA A a3 receptor clusters apposed to the presynaptic marker, VIAAT.
Electron Microscopy
Retinas were fixed by eyecup immersion in 2% paraformaldehye/2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 3 hr. The tissue was then washed in buffer, fixed further in 1% osmium tetroxide in cacodylate buffer for 1 hour prior to en bloc staining with 1% uranyl acetate. The tissue was then dehydrated in graded ethanol series, embedded in araldite resin, sectioned, and stained with 5% lead citrate.
Western Blot
Retinas from GAD1KO and littermate control mice (two retinas pooled per animal) were prepared on ice in homogenizing buffer (50 mM TRIS, 150 mM NaCl, 1% Triton X-100, 1% Na-deoxycholate, and 0.1% SDS) containing protease inhibitor cocktail. Samples (30 mg/ml per lane) were run by SDS-PAGE (10% resolving gel), blotted onto nitrocellulose membranes, incubated with antibodies, and visualized with enhanced chemiluminescence. Primary antibodies utilized were directed against GAD67 (mouse monoclonal, 1:2,000, Chemicon), GABA A a1 receptor subunit (polyclonal rabbit, 1:2,000, kindly provided by J.M. Fritschy), or actin (mouse monoclonal, 1:3,000, Chemicon). For preparation of samples to compare GABA A a1 levels from retinal homogenates, the dorsal-ventral wedge of the retina was not included for both GAD1KO and littermate control samples.
Preparation of Mouse Retinal Slices for Whole-Cell Recording
The preparation of retinal slices has been described in detail by Eggers and Lukasiewicz (2006a) . In brief, the eyecup was incubated for 20 min in mACSF containing 0.5 mg/ml hyaluronidase (Sigma-Aldrich) to remove any remaining vitreous. The retinas were then put onto filter paper (HABP013, Millipore) with the photoreceptor layer facing up. Vertical retinal slices of 200 mm thickness were cut using a standard technique (Werblin, 1978) and subsequently stored in carbogenated mACSF at room temperature.
Whole-Cell Recordings and Data Analysis
Whole-cell recordings were made from and A17s (in GAD1KO and GABA C KO) in retinal slices as previously described (Eggers and Lukasiewicz, 2006a; Schubert et al., 2008) . The resistance of the electrodes with standard solutions usually ranged between 6 and 8 MU. Liquid junction potentials of 15 mV were corrected before measurements with the pipette offset function. Series resistance (mean: 67.6 ± 3.7 MU, n = 18) and capacitance of pipettes as well as cell capacitance were not compensated. Seal resistances >1 GU were routinely obtained. To record GABA-evoked currents and spontaneous inhibitory postsynaptic currents (sIPSCs) in RBCs, we voltage-clamped these cells at 0 mV, the reversal potential for cationmediated currents through ionotropic glutamate receptors. For all RBC recordings, glycinergic input and network activity were blocked by strychnine (0.5 mM) and TTX (1 mM), respectively. For A17 amacrine cells, excitatory postsynaptic currents mediated by ionotropic glutamate receptors (sEPSCs) were recorded at a holding potential of À60 mV, the reversal potential for chloride-mediated currents set by the internal solution (Schubert et al., 2008) . Action potentials in A17s were blocked by including QX-314 (2 mM) in the intracellular solution. For recording sEPSCs from P11-P13 A17s in the presence of GABA receptor blockers, TPMPA (50 mM) and SR95531 (5 mM) were included in the extracellular mACSF solution. The holding current was monitored during the experiment, and recordings with shifting holding currents were aborted. All experiments were carried out at room temperature (20 C-22 C) and under room light conditions.
Data acquisition was performed using an Axopatch 200B amplifier with an acquisition frequency of 10 kHz using the Clampex software (Axon Instruments, Foster City, CA, USA). Signals were 2 kHz Bessel filtered. Data were further processed using a routine written in Igor Pro 6 (Wavemetrics, Portland, OR, USA) and visualized with Origin software (Microcal, Northampton, MA, USA). To quantify parameters of spontaneous synaptic events, the mean frequency ± SEM and the mean peak amplitude ± SEM of the events were determined. To quantify evoked currents, peak amplitude and total charge transfer (as complete area under the curve), both relative to the preapplication baseline current, were determined and averaged across cells. In addition, we characterized the kinetics of the evoked current by determining the time points from the exponential fits at which the traces reached 20% and 80% of the peak amplitude and calculated the differences, t20-80 rise and t80-20 decay.
Solution and Drugs
The extracellular solution used for recording (mACSF) contained (in mM) 122.5 NaCl, 5 KCl, 1 MgCl 2 , 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 2 CaCl 2 , and 20 glucose, adjusted to pH 7.4 with 95% O 2 and 5% CO 2 . The intracellular solution contained (in mM) 120 cesium gluconate, 1 CaCl 2 , 1 MgCl 2 , 10 Na-HEPES, 11 EGTA, and 10 TEA-Cl and was adjusted to pH 7.2 with CsOH. Under our experimental conditions, the calculated chloride equilibrium potential was À59.3 mV. To block GABA C receptors and GABA A receptors, (1,2,5,6-tetrahydropyridine-4yl) methyphospinic acid (TPMPA, 50 mM) and SR95531 (5 mM) were used, respectively. All drugs were purchased from Sigma-Aldrich. Solutions in the recording chamber were exchanged using a gravity-driven superfusion system previously described (Lukasiewicz and Roeder, 1995) . GABA receptor and glutamate receptor agonists, GABA (200 mM) and AMPA (100 mM), were dissolved in mACSF with 0.005% sulforhodamine B and applied with a puff pipette (5-7 MU) using a Picospritzer system. Puffing directions, as well as the duration of the 300 ms puff, were chosen such that the axonal terminal of the patched RBC was completely covered by the puff, visualized by including sulforhodamine B in the puffer pipette.
Statistics
For comparisons across data sets, the Wilcoxon rank-sum test was used in all cases. *p < 0.05; **p < 0.01; ***p < 0.001.
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